PCVX
Vaxcyte, Inc.
49 disclosed insider filings · 6 distinct insiders · latest Oct 7, 2026
Total filings
49
6 insiders
Insider buys
0
$0
Insider sells
24
$6.4M
Grants & other
0
$0
All disclosed filings
Same-day tranches are grouped per insider - the Lots column shows how many individual executions a row covers; Price is the value-weighted average.
| Filed | Tx date | Insider | Type | Qty | Avg price | Value | Lots | Source |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sep 1, 2026 | Jim Wassil OFFICER | SELL | 3,477 | $61.07 | $212K | 4 | EDGAR |
| Sep 2, 2026 | Aug 31, 2026 | Andrew Guggenhime OFFICER | OTHER | 1,273 | $60.74 | $77K | — | EDGAR |
| Sep 2, 2026 | Aug 31, 2026 | Grant Pickering OFFICER | OTHER | 2,862 | $60.74 | $174K | — | EDGAR |
| Sep 2, 2026 | Aug 31, 2026 | Elvia Cowan OFFICER | OTHER | 243 | $60.74 | $15K | — | EDGAR |
| Sep 2, 2026 | Aug 31, 2026 | Jim Wassil OFFICER | OTHER | 1,273 | $60.74 | $77K | — | EDGAR |
| Sep 2, 2026 | Aug 31, 2026 | Harpreet S Dhaliwal OFFICER | OTHER | 361 | $60.74 | $22K | — | EDGAR |
| Aug 5, 2026 | Aug 5, 2026 | Harpreet S Dhaliwal OFFICER | OTHER | 17,000 | $24.79 | $421K | — | EDGAR |
| Aug 5, 2026 | Aug 5, 2026 | Harpreet S Dhaliwal OFFICER | SELL | 17,000 | $55 | $935K | — | EDGAR |
| Aug 5, 2026 | Aug 3, 2026 | Jim Wassil OFFICER | OTHER | 2,250 | $5.35 | $12K | — | EDGAR |
| Aug 5, 2026 | Aug 3, 2026 | Jim Wassil OFFICER | SELL | 2,250 | $53.86 | $121K | 2 | EDGAR |
| Aug 5, 2026 | Aug 3, 2026 | Andrew Guggenhime OFFICER | OTHER | 10,000 | $5.35 | $54K | — | EDGAR |
| Aug 5, 2026 | Aug 3, 2026 | Andrew Guggenhime OFFICER | SELL | 10,000 | $53.89 | $539K | 2 | EDGAR |
| Jul 28, 2026 | Jul 27, 2026 | Grant Pickering OFFICER | OTHER | 16,198 | $2.03 | $33K | — | EDGAR |
| Jul 28, 2026 | Jul 27, 2026 | Grant Pickering OFFICER | SELL | 18,198 | $55.63 | $1.0M | 6 | EDGAR |
| Jul 6, 2026 | Jul 1, 2026 | Jim Wassil OFFICER | SELL | 2,250 | $56.33 | $127K | 3 | EDGAR |
| Jul 6, 2026 | Jul 1, 2026 | Jim Wassil OFFICER | OTHER | 516 | $5.35 | $3K | — | EDGAR |
← PrevPage 2 of 2